The DOI matches its Crossref record; 121 of the 121 references it cites were found in a registry or an index.
Apoptotic and antiapoptotic mechanisms in stroke
Abstract
Apoptosis is a form of programmed cell death that occurs in neurons during development of the nervous system and may also be a prominent form of neuronal death in chronic neurodegenerative disorders such as Alzheimer's and Parkinson's diseases. Recent findings also implicate apoptosis in neuronal degeneration after ischemic brain injury in animal models of stroke. Activation of both apoptotic and antiapoptotic signaling cascades occurs in neurons in animal and cell culture models of stroke. Apoptotic cascades involve: increased levels of intracellular oxyradicals and calcium; induction of expression of proteins such as Par-4 (prostate apoptosis response-4), which act by promoting mitochondrial dysfunction and suppressing antiapoptotic mechanisms; mitochondrial membrane depolarization, calcium uptake, and release of factors (e.g., cytochrome c) that ultimately induce nuclear DNA condensation and fragmentation; activation of cysteine proteases of the caspase family; activation of transcription factors such as AP-1 that may induce expression of "killer genes." Antiapoptotic signaling pathways are activated by neurotrophic factors, certain cytokines, and increases in oxidative and metabolic stress. Such protective pathways include: activation of the transcription factors (e.g., nuclear factor-kappa B, NF-kappa B) that induce expression of stress proteins, antioxidant enzymes, and calcium-regulating proteins; phosphorylation-mediated modulation of ion channels and membrane transporters; cytoskeletal alterations that modulate calcium homeostasis; and modulation of proteins that stabilize mitochondrial function (e.g., Bcl-2). Intervention studies in experimental stroke models have identified a battery of approaches of potential benefit in reducing neuronal death in stroke patients, including administration of antioxidants, calcium-stabilizing agents, caspase inhibitors, and agents that activate NF-kappa B. Interestingly, recent studies suggest novel dietary approaches (e.g., food restriction and supplementation with antioxidants) that may reduce brain damage following stroke.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Focal cerebral ischemia by middle cerebral artery occlusion (MCAo) induces apoptotic neural cell death that is primarily localized to the area immediately adjacent to the infarcted tissue, known as the ischemic boundary zone (IBZ) [1].”
From MicroRNA‐21 protects neurons from ischemic death (2010) · cites this paper as [1]
Citations
Cites
The Release of Cytochrome c from Mitochondria: A Primary Site for Bcl-2 Regulation of Apoptosis
Kluck, R. M., Bossy‐Wetzel, E., Green, D. R., & Newmeyer, D. D. (1997) · Science · doi:10.1126/science.275.5303.1132 · Cited by 4,715
Pathobiology of ischaemic stroke: an integrated view
Dirnagl, U., Iadecola, C., & Moskowitz, M. A. (1999) · Trends in Neurosciences · doi:10.1016/s0166-2236(99)01401-0 · Cited by 3,943
Bcl-2 functions in an antioxidant pathway to prevent apoptosis
Hockenbery, D. M., Oltvai, Z. N., Yin, X., Milliman, C. L., & Korsmeyer, S. J. (1993) · Cell · doi:10.1016/0092-8674(93)80066-n · Cited by 3,402
Ankarcrona, M., Dypbukt, J. M., Bonfoco, E., Zhivotovsky, B., Orrenius, S., Lipton, S. A., & Nicotera, P. (1995) · Neuron · doi:10.1016/0896-6273(95)90186-8 · Cited by 1,884
Mitochondrial control of apoptosis
Kroemer, G., Zamzami, N., & Susín, S. A. (1997) · Immunology Today · doi:10.1016/s0167-5699(97)80014-x · Cited by 1,476
Role of Oxidants in Ischemic Brain Damage
Chan, P. H. (1996) · Stroke · doi:10.1161/01.str.27.6.1124 · Cited by 1,027
Bruce‐Keller, A. J., Boling, W., Kindy, M. S., Peschon, J. J., Kraemer, P. J., Carpenter, M. K., Holtsberg, F. W., & Mattson, M. P. (1996) · Nature Medicine · doi:10.1038/nm0796-788 · Cited by 934
Self-citationKeller, J. N., Kindy, M. S., Holtsberg, F. W., St. Clair, D. K., Yen, H.-C., Germeyer, A., Steiner, S. M., Bruce-Keller, A. J., Hutchins, J. B., & Mattson, M. P. (1998) · The Journal of Neuroscience · doi:10.1523/jneurosci.18-02-00687.1998 · Cited by 863
Self-citationHara, H., Friedlander, R. M., Gagliardini, V., Ayata, C., Fink, K., Huang, Z., Shimizu‐Sasamata, M., Yuan, J., & Moskowitz, M. A. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.5.2007 · Cited by 835
Nitatori, T., Sato, N., Waguri, S., Karasawa, Y., Araki, H., Shibanai, K., Kominami, E., & Uchiyama, Y. (1995) · Journal of Neuroscience · doi:10.1523/jneurosci.15-02-01001.1995 · Cited by 832
Cited by
Sorted by citations
Neurotrophic and neuroprotective actions of estrogen: Basic mechanisms and clinical implications
Brann, D. W., Dhandapani, K. M., Wakade, C. G., Mahesh, V. B., & Khan, M. M. (2007) · Steroids · doi:10.1016/j.steroids.2007.02.003 · Cited by 677
Pathophysiology, treatment, and animal and cellular models of human ischemic stroke
Woodruff, T., Thundyil, J., Tang, S.-C., Sobey, C., Taylor, S., & Arumugam, T. (2011) · Molecular Neurodegeneration · doi:10.1186/1750-1326-6-11 · Cited by 594
Oxidants, antioxidants and the ischemic brain
Warner, D. S., Sheng, H., & Batinic̈‐Haberle, I. (2004) · Journal of Experimental Biology · doi:10.1242/jeb.01022 · Cited by 598
Almeida, R. D., Manadas, B. J., Melo, C. V., Gomes, J. R., Mendes, C. S., Grãos, M., Carvalho, R. F., Carvalho, A. P., & Duarte, C. B. (2005) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4401662 · Cited by 592
Non-invasive detection of apoptosis using magnetic resonance imaging and a targeted contrast agent
Zhao, M. F., Beauregard, D. A., Loizou, L., Davletov, B. A., & Brindle, K. M. (2001) · Nature Medicine · doi:10.1038/nm1101-1241 · Cited by 524
Mattiasson, G., Shamloo, M., Gido, G., Mathi, K., Tomasevic, G., Yi, S., Warden, C. H., Castilho, R. F., Melcher, T., Gonzalez-Zulueta, M., et al. (2003) · Nature Medicine · doi:10.1038/nm903 · Cited by 515
Pathophysiology and therapy of experimental stroke
Hossmann, K.-A. (2006) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-006-9008-1 · Cited by 475
Phospholipase A2, reactive oxygen species, and lipid peroxidation in cerebral ischemia
Rao, A. M., & Hatcher, J. F. (2005) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2005.08.044 · Cited by 392
Mitochondrial function in hypoxic ischemic injury and influence of aging
Ham, P. B., & Raju, R. P. (2016) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2016.06.006 · Cited by 374
Culmsee, C., Zhu, C., Landshamer, S., Becattini, B., Wagner, E., Pellecchia, M., Blomgren, K., & Plesnila, N. (2005) · Journal of Neuroscience · doi:10.1523/jneurosci.2818-05.2005 · Cited by 339
Self-citationPathophysiology of Stroke: Lessons from Animal Models
Mergenthaler, P., Dirnagl, U., & Meisel, A. (2004) · Metabolic Brain Disease · doi:10.1023/b:mebr.0000043966.46964.e6 · Cited by 325
Mitochondria in cell death: novel targets for neuroprotection and cardioprotection
Mattson, M. P., & Kroemer, G. (2003) · Trends in Molecular Medicine · doi:10.1016/s1471-4914(03)00046-7 · Cited by 264
Self-citationRyu, H., Lee, J.-H., Olofsson, B. A., Mwidau, A., Deodoglu, A., Escudero, M., Flemington, E. K., Azizkhan‐Clifford, J., Ferrante, R. J., & Ratan, R. R. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0737363100 · Cited by 262
MicroRNA‐21 protects neurons from ischemic death
Buller, B., Liu, X., Wang, X., Zhang, R. L., Zhang, L., Hozeska‐Solgot, A., Chopp, M., & Zhang, Z. G. (2010) · The FEBS Journal · doi:10.1111/j.1742-4658.2010.07818.x · Cited by 242
Zhang, Q.-G., Raz, L., Wang, R., Han, D. K., Sevilla, L. M. D., Yang, F., Vadlamudi, R. K., & Brann, D. W. (2009) · Journal of Neuroscience · doi:10.1523/jneurosci.3574-09.2009 · Cited by 242
The Antiapoptotic Activity of Melatonin in Neurodegenerative Diseases
Wang, X. (2009) · CNS Neuroscience & Therapeutics · doi:10.1111/j.1755-5949.2009.00105.x · Cited by 232
Citicoline: pharmacological and clinical review, 2010 update.
Secades, J. J. (2011) · PubMed · Cited by 216
Neuronal Life-and-Death Signaling, Apoptosis, and Neurodegenerative Disorders
Mattson, M. P. (2006) · Antioxidants and Redox Signaling · doi:10.1089/ars.2006.8.1997 · Cited by 211
Self-citationLiu, D., Lu, C., Wan, R., Auyeung, W. W., & Mattson, M. P. (2002) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/00004647-200204000-00007 · Cited by 217
Self-citationGhrelin Inhibits Apoptosis in Hypothalamic Neuronal Cells during Oxygen-Glucose Deprivation
Chung, H., Kim, E., Lee, D. H., Seo, S., Ju, S., Lee, D., Kim, H., & Park, S. (2006) · Endocrinology · doi:10.1210/en.2006-0991 · Cited by 199
Apoptotic Pathways and Alzheimer’s Disease: Probing Therapeutic Potential
Sharma, V., Singh, T. G., Singh, S., Garg, N., & Dhiman, S. (2021) · Neurochemical Research · doi:10.1007/s11064-021-03418-7 · Cited by 201
Cytidine 5?-Diphosphocholine (CDP-Choline) in Stroke and Other CNS Disorders
Rao, A. M., & Hatcher, J. F. (2005) · Neurochemical Research · doi:10.1007/s11064-004-9681-8 · Cited by 192
The Emerging Functions of UCP2 in Health, Disease, and Therapeutics
Mattiasson, G., & Sullivan, P. G. (2006) · Antioxidants and Redox Signaling · doi:10.1089/ars.2006.8.1 · Cited by 181
Nuclear Translocation of Apoptosis-Inducing Factor after Focal Cerebral Ischemia
Plesnila, N., Zhu, C., Culmsee, C., Gröger, M., Moskowitz, M. A., & Blomgren, K. (2004) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/00004647-200404000-00011 · Cited by 168
Self-citationTherapeutic Hypothermia: Critical Review of the Molecular Mechanisms of Action
González-Ibarra, F. P., Varón, J., & López-Meza, E. G. (2011) · Frontiers in Neurology · doi:10.3389/fneur.2011.00004 · Cited by 173
Suzaki, Y., Yoshizumi, M., Kagami, S., Koyama, A. H., Taketani, Y., Houchi, H., Tsuchiya, K., Takeda, E., & Tamaki, T. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m111790200 · Cited by 163
PPAR-γ: therapeutic target for ischemic stroke
Culman, J., Zhao, Y., Gohlke, P., & Herdegen, T. (2007) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2007.03.004 · Cited by 154
Cell-based Therapy for Acute Organ Injury
Monsel, A., Zhu, Y., Gennai, S., Hao, Q., Liu, J., & Lee, J. W. (2014) · Anesthesiology · doi:10.1097/aln.0000000000000446 · Cited by 158
Ultrastructural Changes of Neuronal Mitochondria After Transient and Permanent Cerebral Ischemia
Solenski, N. J., diPierro, C. G., Trimmer, P. A., Kwan, A.-L., & Helms, G. A. (2002) · Stroke · doi:10.1161/hs0302.104541 · Cited by 157
Hepatitis B Virus X Protein Induces Cell Death by Causing Loss of Mitochondrial Membrane Potential
Shirakata, Y., & Koike, K. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m301606200 · Cited by 155
Culmsee, C., Gerling, N., Lehmann, M., Nikolova‐Karakashian, M., Prehn, J. H. M., Mattson, M. P., & Krieglstein, J. (2002) · Neuroscience · doi:10.1016/s0306-4522(02)00539-0 · Cited by 154
Self-citationLyu, Z., Park, J., Kim, K., Jin, H.-J., Wu, H., Rajadas, J., Kim, D., Steinberg, G. K., & Lee, W. (2021) · Nature Biomedical Engineering · doi:10.1038/s41551-021-00744-7 · Cited by 148
Zhou, C., Yamaguchi, M., Kusaka, G., Schonholz, C. J., Nanda, A., & Zhang, J. H. (2004) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/00004647-200404000-00007 · Cited by 147
Pei, X., Li, Y., Zhu, L., & Zhou, Z.-L. (2019) · Experimental Cell Research · doi:10.1016/j.yexcr.2019.06.019 · Cited by 146
Visualizing Cell Death in Experimental Focal Cerebral Ischemia: Promises, Problems, and Perspectives
Zille, M., Farr, T. D., Przesdzing, I., Müller, J. M., Sommer, C., Dirnagl, U., & Wunder, A. (2011) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2011.150 · Cited by 142
Acute Neuronal Injury, Excitotoxicity, and the Endocannabinoid System
van der Stelt, M., Veldhuis, W. B., Maccarrone, M., Bär, P. R., Nicolay, K., Veldink, G. A., Marzo, V. D., & Vliegenthart, J. F. G. (2002) · Molecular Neurobiology · doi:10.1385/mn:26:2-3:317 · Cited by 143
Chung, H., Seo, S., Moon, M., & Park, S. (2008) · Journal of Endocrinology · doi:10.1677/joe-08-0160 · Cited by 144
Genomic approach to selective vulnerability of the hippocampus in brain ischemia–hypoxia
Schmidt‐Kastner, R. (2015) · Neuroscience · doi:10.1016/j.neuroscience.2015.08.034 · Cited by 139
Ginis, I., Jaiswal, R. K., Klimanis, D., Liu, J., Greenspon, J., & Hallenbeck, J. M. (2002) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/00004647-200202000-00002 · Cited by 138
microRNAs: Innovative Targets for Cerebral Ischemia and Stroke
Ouyang, Y., Stary, C. M., Yang, G., & Giffard, R. G. (2012) · Current Drug Targets · doi:10.2174/138945013804806424 · Cited by 140
Oxidative Stress and Inflammation in Brain Aging: Nutritional Considerations
Joseph, J. A., Shukitt‐Hale, B., Casadesús, G., & Fisher, D. (2005) · Neurochemical Research · doi:10.1007/s11064-005-6967-4 · Cited by 137
Andrabi, S. A., Spina, M. G., Lorenz, P., Ebmeyer, U., Wolf, G. L., & Horn, T. F. W. (2004) · Brain Research · doi:10.1016/j.brainres.2004.05.038 · Cited by 136
Gary, D. S., & Mattson, M. P. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00173.x · Cited by 136
Self-citationGlazner, G. W., Chan, S. L., Lu, C., & Mattson, M. P. (2000) · Journal of Neuroscience · doi:10.1523/jneurosci.20-10-03641.2000 · Cited by 134
Self-citationHormesis/preconditioning mechanisms, the nervous system and aging
Arumugam, T. V., Gleichmann, M., Tang, S., & Mattson, M. P. (2006) · Ageing Research Reviews · doi:10.1016/j.arr.2006.03.003 · Cited by 131
Self-citationMattson, M. P., Duan, W., Wan, R., & Guo, Z. (2004) · Neurotherapeutics · doi:10.1602/neurorx.1.1.111 · Cited by 133
Self-citationBarczyk, K., Kreuter, M., Pryjma, J. R., Booy, E. P., Maddika, S., Ghavami, S., Berdel, W. E., Roth, J., & Łoś, M. (2005) · International Journal of Cancer · doi:10.1002/ijc.21037 · Cited by 127
RNA Interference in Biology and Medicine
Milhavet, O., Gary, D. S., & Mattson, M. P. (2003) · Pharmacological Reviews · doi:10.1124/pr.55.4.1 · Cited by 127
Self-citationChatterjee, S., Zaman, K., Ryu, H., Conforto, A. B., & Ratan, R. R. (2001) · Annals of Neurology · doi:10.1002/ana.71.abs · Cited by 126
Holopainen, I. E. (2005) · Neurochemical Research · doi:10.1007/s11064-005-8829-5 · Cited by 128
Purinergic 2X7 receptor/NLRP3 pathway triggers neuronal apoptosis after ischemic stroke in the mouse
Ye, X., Shen, T., Hu, J., Zhang, L., Zhang, Y., Bao, L., Cui, C., Jin, G., Zan, K., Zhang, Z., et al. (2017) · Experimental Neurology · doi:10.1016/j.expneurol.2017.03.002 · Cited by 121
Rao, A. M., Hatcher, J. F., Larsen, E. C., Chen, X., Sun, D., & Tsao, F. H. C. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m512112200 · Cited by 121
RetractedEcheverrı́a, V., Clerman, A., & Doré, S. (2005) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2005.04427.x · Cited by 122
Intranasal Insulin and Insulin-Like Growth Factor 1 as Neuroprotectants in Acute Ischemic Stroke
Lioutas, V., Alfaro-Martinez, F., Bedoya, F. J., Chung, C., Maldonado, D. P., & Novak, V. (2015) · Translational Stroke Research · doi:10.1007/s12975-015-0409-7 · Cited by 115
Penkowa, M., & Hidalgo, J. (2001) · Experimental Neurology · doi:10.1006/exnr.2001.7675 · Cited by 109
Gahete, M. D., Córdoba‐Chacón, J., Kineman, R. D., Luque, R. M., & Castano, J. P. (2011) · Peptides · doi:10.1016/j.peptides.2011.09.019 · Cited by 109
Prospects for antiapoptotic drug therapy of neurodegenerative diseases
Waldmeier, P. C. (2003) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/s0278-5846(03)00025-3 · Cited by 106
Mechanisms of hyperbaric oxygen and neuroprotection in stroke
Zhang, J. H., Lo, T., Mychaskiw, G., & Colohan, A. R. T. (2005) · Pathophysiology · doi:10.1016/j.pathophys.2005.01.003 · Cited by 105
Cadet, J. L., Jayanthi, S., McCoy, M. T., Vawter, M. P., & Ladenheim, B. (2001) · Synapse · doi:10.1002/syn.1058 · Cited by 103
Cole, K. K., & Perez-Polo, J. R. (2002) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2002.00935.x · Cited by 104
Hyperbaric oxygen therapy and cerebral ischemia: neuroprotective mechanisms
Matchett, G. A., Martin, R., & Zhang, J. H. (2009) · Neurological Research · doi:10.1179/174313209x389857 · Cited by 104
Culmsee, C., Junker, V., Kremers, W., Thal, S. C., Plesnila, N., & Krieglstein, J. (2004) · Stroke · doi:10.1161/01.str.0000125855.17686.6d · Cited by 101
Self-citationRapamycin protects against middle cerebral artery occlusion induced focal cerebral ischemia in rats
Chauhan, A., Sharma, U., Jagannathan, N. R., Reeta, K. H., & Gupta, Y. K. (2011) · Behavioural Brain Research · doi:10.1016/j.bbr.2011.08.035 · Cited by 99
Peng, Z., Li, J., Li, Y., Yang, X., Feng, S., Han, S., & Li, J. (2013) · Journal of Neuroscience Research · doi:10.1002/jnr.23255 · Cited by 99
Repeated mild injury causes cumulative damage to hippocampal cells
Slemmer, J. E. (2002) · Brain · doi:10.1093/brain/awf271 · Cited by 97
Mechanisms of gender-linked ischemic brain injury
Liu, M., Dziennis, S., Hurn, P. D., & Alkayed, N. J. (2009) · Restorative Neurology and Neuroscience · doi:10.3233/rnn-2009-0467 · Cited by 95
NF-κB, a Potential Therapeutic Target for the Treatment of Multiple Sclerosis
Yan, J., & Greer, J. M. (2008) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/187152708787122941 · Cited by 96
Yoshizumi, M., Kogame, T., Suzaki, Y., Fujita, Y., Kyaw, M. H., Kirima, K., Ishizawa, K., Tsuchiya, K., Kagami, S., & Tamaki, T. (2002) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0704808 · Cited by 93
Tseng, Y., Hsu, Y.-Y., Shih, Y., & Lo, Y. (2011) · Shock · doi:10.1097/shk.0b013e31823fe939 · Cited by 93
Lou, M., Blume, A., Zhao, Y., Gohlke, P., Deuschl, G., Herdegen, T., & Čulman, J. (2004) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/00004647-200405000-00008 · Cited by 90
Wakade, C. G., Khan, M. M., Sevilla, L. M. D., Zhang, Q., Mahesh, V. B., & Brann, D. W. (2007) · Endocrinology · doi:10.1210/en.2007-0899 · Cited by 90
Involvement of mitochondrial K+ release and cellular efflux in ischemic and apoptotic neuronal death
Liu, D., Slevin, J. R., Lu, C., Chan, S. L., Hansson, M. J., Elmér, E., & Mattson, M. P. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.01913.x · Cited by 88
Self-citationInfectious agents and age-related neurodegenerative disorders
Mattson, M. P. (2003) · Ageing Research Reviews · doi:10.1016/j.arr.2003.08.005 · Cited by 87
Self-citationWang, Q., Gong, Q., Wu, Q., & Shi, J. (2009) · Phytomedicine · doi:10.1016/j.phymed.2009.05.010 · Cited by 85
Anti-Amyloidogenic and Anti-Apoptotic Role of Melatonin in Alzheimer Disease
He, H., Dong, W., & Huang, F. P. (2010) · Current Neuropharmacology · doi:10.2174/157015910792246137 · Cited by 83
Arumugam, T. V., Cheng, Y., Choi, Y., Choi, Y., Yang, S.-H., Yun, Y., Park, J., Yang, D. K., Thundyil, J., Gelderblom, M., et al. (2011) · Molecular Pharmacology · doi:10.1124/mol.111.071076 · Cited by 81
Apoptosis: Future Targets for Neuroprotective Strategies
Ferrer, I. (2006) · Cerebrovascular Diseases · doi:10.1159/000091699 · Cited by 80
Arthur, P. G., Lim, S. C. C., Meloni, B. P., Munns, S. E., Chan, A. S. M., & Knuckey, N. (2004) · Brain Research · doi:10.1016/j.brainres.2004.05.031 · Cited by 80
Gärtner, W. (2001) · Cerebral Cortex · doi:10.1093/cercor/11.12.1161 · Cited by 79
Culmsee, C., Bondada, S., & Mattson, M. P. (2001) · Molecular Brain Research · doi:10.1016/s0169-328x(01)00008-0 · Cited by 78
Self-citationGribkoff, V. K., & Bozik, M. E. (2008) · CNS Neuroscience & Therapeutics · doi:10.1111/j.1755-5949.2008.00048.x · Cited by 77
Integration of cytokine biology and lipid metabolism in stroke
Rao, A. M. (2007) · Frontiers in bioscience · doi:10.2741/2759 · Cited by 77
Masuda, M., Nagashima, R., Kanzaki, S., Fujioka, M., Ogita, K., & Ogawa, K. (2005) · Brain Research · doi:10.1016/j.brainres.2005.11.020 · Cited by 75
Li, L., Feng, Z., & Porter, A. G. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m310415200 · Cited by 74
Sucher, N. J. (2006) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2005.11.015 · Cited by 75
NF-κB, IκB, and IRAK Control Glutamate Receptor Density at the Drosophila NMJ
Heckscher, E. S., Fetter, R. D., Marek, K. W., Albin, S. D., & Davis, G. W. (2007) · Neuron · doi:10.1016/j.neuron.2007.08.005 · Cited by 72
Cocaine induces cell death and activates the transcription nuclear factor kappa-b in pc12 cells
Lepsch, L. B., Munhoz, C. D., Kawamoto, E. M., Yshii, L., Lima, L. S., Cury‐Boaventura, M. F., Salgado, T. M., Curi, R., Planeta, C. S., & Scavone, C. (2009) · Molecular Brain · doi:10.1186/1756-6606-2-3 · Cited by 71
NF-κB protects neurons from ischemic injury after middle cerebral artery occlusion in mice
Duckworth, E. A. M., Butler, T. L., Collier, L. A., Collier, S., & Pennypacker, K. R. (2006) · Brain Research · doi:10.1016/j.brainres.2006.02.103 · Cited by 71
Li, F., Hayashi, T., Jin, G., Deguchi, K., Nagotani, S., Nagano, I., Shoji, M., Chan, P. H., & Abe, K. (2005) · Brain Research · doi:10.1016/j.brainres.2005.04.058 · Cited by 68
Estructura y función de las subunidades del receptor a glutamato tipo NMDA
Flores-Soto, M. E., Chaparro-Huerta, V., Escoto-Delgadillo, M., Vázquez-Valls, E., González-Castañeda, R. E., & Beas‐Zárate, C. (2012) · Neurología · doi:10.1016/j.nrl.2011.10.014 · Cited by 73
Feng, Y., Liu, Y.-M., Fratkins, J. D., & LeBlanc, M. H. (2005) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2005.04.006 · Cited by 66
Calorie restriction and stroke
Manzanero, S., Gelderblom, M., Magnus, T. U., & Arumugam, T. V. (2011) · Experimental & Translational Stroke Medicine · doi:10.1186/2040-7378-3-8 · Cited by 65
Mitochondrial transplantation in cardiomyocytes: foundation, methods, and outcomes
Pour, P. A., Hosseinian, S., & Kheradvar, A. (2021) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00152.2021 · Cited by 65
Structure and function of NMDA-type glutamate receptor subunits
Flores-Soto, M. E., Chaparro-Huerta, V., Escoto-Delgadillo, M., Vázquez-Valls, E., González-Castañeda, R. E., & Beas‐Zárate, C. (2012) · Neurología (English Edition) · doi:10.1016/j.nrleng.2011.10.003 · Cited by 64
Okun, E., Arumugam, T. V., Tang, S., Gleichmann, M., Albeck, M., Sredni, B., & Mattson, M. P. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.04615.x · Cited by 63
Self-citationYang, C., Yang, W., He, Z., Guo, J., Yang, X., Wang, R., & Li, H. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.624402 · Cited by 63
Sun, M., & Xu, C. (2007) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-007-9183-8 · Cited by 62
Cao, Y.-J., Shibata, T., & Rainov, N. G. (2002) · Gene Therapy · doi:10.1038/sj.gt.3301676 · Cited by 62
Beer, R., Franz, G., Krajewski, S., Pike, B. R., Hayes, R. L., Reed, J. C., Wang, K., Klimmer, C., Schmutzhard, E., Poewe, W. H., et al. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00460.x · Cited by 61
Liu, H., Xin, L., Chan, B. P. L., Teoh, R., Tang, B. L., & Tan, Y. H. (2002) · Neuroscience Letters · doi:10.1016/s0304-3940(02)00371-3 · Cited by 60
Metadata
- Authors
- Mattson, M. P., Culmsee, C., & Yu, Z. F.
- Affiliations
- National Institute on Aging (US)
- Corresponding author
- Mattson, Mark P.
- Venue
- Cell and Tissue Research
- Published
- 2000-03-23
- Volume
- 301
- Issue
- 1
- Pages
- 173-187
- ISSN
- 0302-766X (ISSN-L)
- 1432-0878
- OpenAlex
- W2147278993
- Cited by
- 318
- References
- 121
- Citations by year
- 2026: 2 · 2025: 3 · 2024: 7 · 2023: 6 · 2022: 5 · 2021: 10 · 2020: 4 · 2019: 4 · 2018: 8 · 2017: 9 · 2016: 5 · 2015: 7 · 2014: 16 · 2013: 9 · 2012: 16
- FWCI
- 7.48
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Cell and Tissue Research (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cell death mechanisms and regulation
- Health Sciences › Medicine › Clinical Neurology › Acute Ischemic Stroke Management
- Life Sciences › Neuroscience › Neurology › Neuroprotection in Cerebral Ischemia
- Keywords
- apoptosis, stroke, ischemic brain injury, neuronal cell death, anti-apoptotic signaling, mitochondrial dysfunction, caspases, cytochrome c release, NF-κB, Bcl-2, neurotrophic factors, oxidative stress, calcium homeostasis, antioxidants, caspase inhibitors, dietary restriction, dietary supplementation
- MeSH terms
- Animals, Brain, Calcium, Carrier Proteins, Cell Nucleus, Brain Ischemia, Humans, Mitochondria, Models, Biological, Nerve Growth Factors, Neurons, Signal Transduction, Gene Expression, Cytokines, Apoptosis, Reactive Oxygen Species, Stroke, Intracellular Signaling Peptides and Proteins, Apoptosis Regulatory Proteins, Mice, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review